ICG & Management & Private Investors take majority stake in Domusvi
Context
DomusVi completed a major capital reorganization, described as a "jumbo-LBO". This transaction allowed founder Yves Journel to increase his ownership from 30% to 49%, while ICG remains a key controlling partner. The group's management team also participated in the round, investing approximately €50 million for a 2% stake. The deal was financed through a robust structure including €1.6 billion in portable senior debt (representing 6.3x EBITDA) and a €400 million PIK (Payment-in-Kind) line provided by ICG. The strategic rationale is to fund a "European conquest" phase, aiming to double the group's revenue to €3.4 billion by 2025. This growth will be driven by massive external acquisitions in Germany, Italy, Belgium, and Portugal, further consolidating DomusVi's position as a dominant European healthcare provider.
Domusvi, which reported an EBITDA margin of [members only] in 2020, is valued in this transaction at an EV/EBITDA multiple of 15x–25x.
-> Deep-dive in Healthcare & Pharma market trends
Target
DomusVi stands as a leading international provider of high-quality elderly care and specialized services. The group operates an extensive cross-border network across Europe and Latin America, encompassing medicalized nursing homes, mental health facilities, and home care agencies. The entity actively executes a targeted buy-and-build strategy aimed at securing and strengthening its premier position within its domestic market. DomusVi’s value proposition is built upon a multi-disciplinary approach to dependency and senior care, seamlessly integrating medicalized residential care, specialized disability centers, and home assistance solutions to deliver a comprehensive support ecosystem for seniors and their families.
Ent. Value
€1–10bn
Equity Value
[members only]
Multiples
EV / Revenue
2x–6x
EV / EBITDA
15x–25x
EV / EBIT
[members only]
Historical Financials (EUR)
Other operations with Domusvi
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 03/2019 | DOMUSVI | RESIDALYA | FRANCE | Nursing Homes |
| 06/2017 | ICG / MANAGEMENT & PRIVATE INVESTORS | DOMUSVI | FRANCE | Nursing Homes |
| 10/2016 | DOMUSVI | SARQUAVITAE | SPAIN | Nursing Homes |
| 06/2014 | PAI PARTNERS | DOMUSVI | FRANCE | Nursing Homes |
Other operations with ICG / Management & Private Investors
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 07/2021 | ICG | INFRA GROUP | BELGIUM | Utilities Networks (Water/Fiber) |
| 05/2021 | ICG | CIRCET | FRANCE | IT Services |
| 04/2019 | ICG / MERIEUX EQUITY PARTNERS | DOC GENERICI | ITALY | Generics / Labs |
| 08/2018 | MANAGEMENT & PRIVATE INVESTORS | DESIGUAL | SPAIN | Fashion & Apparel |
| 07/2018 | MANAGEMENT & PRIVATE INVESTORS | BETJEMAN & BARTON | FRANCE | Coffee & Tea |
| 06/2017 | ICG / MANAGEMENT & PRIVATE INVESTORS | DOMUSVI | FRANCE | Nursing Homes |
| 06/2017 | HG CAPITAL / GIC / MONTAGU PRIVATE EQUITY / ICG | VISMA GROUP | NORWAY | ERP, HR & Finance |
| 12/2016 | ICG | PARK HOLIDAYS | UNITED KINGDOM | Hospitality |
| 09/2015 | ICG | COURTEPAILLE | FRANCE | Restaurants / Chains |
| 06/2015 | ICG | STELLA | FRANCE | External Joinery |
Similar deals in Health Providers
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 07/2021 | OMERS | AMEDES | GERMANY | Labs (Biology) |
| 05/2021 | INFRATIL | PACIFIC RADIOLOGY GROUP | NEW ZEALAND | Radiology |
| 04/2021 | AMERICAN SECURITIES | SIMONMED IMAGING | UNITED STATES | Radiology |
| 03/2021 | EQT PARTNERS | CERBA HEALTHCARE | FRANCE | Labs (Biology) |
| 03/2021 | TRITON PARTNERS | BERGMAN CLINICS | NETHERLANDS | Clinics / Hospitals |
| 02/2021 | SILVER LAKE / NESTLE | IVC EVIDENSIA | UNITED KINGDOM | Vet Clinics |
| 12/2020 | FRESENIUS | EUGIN GROUP | SPAIN | Outpatient Care |
| 12/2020 | ANTIN INFRASTRUCTURE | HIPPOCRATES (LAF - LA FARMACIA) | ITALY | Pharmacy |
| 12/2020 | RADIOLOGY PARTNERS | MEDNAX RADIOLOGY SOLUTIONS | UNITED STATES | Radiology |
| 12/2020 | MEDIAN KLINIKEN | PRIORY GROUP | UNITED KINGDOM | Clinics / Hospitals |
REFERENCES
Valuation range: EV €1–10bn
Revenue range: €1–10bn
EBITDA range: €250–500M
EV/Revenue range: 2x - 6x
EV/EBITDA range: 15x - 25x
Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of Domusvi by ICG / Management & Private Investors are reserved for mynth community members. Register for free to unlock full data.
Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.
FAQ
What transaction does this page cover?
How was the acquisition of Domusvi by ICG valued, and what multiples were paid?
What were Domusvi’s revenue and EBITDA at the time of the deal?
What sources support the information on this transaction?
What is mynth?